期刊文献+

伊贝沙坦与苯那普利治疗原发性高血压的疗效比较 被引量:4

Comparison of effects between irbesartan and benazepril monotherapy in essential hypertension
下载PDF
导出
摘要 目的 :用 2 4h动态血压监测 (ABPM)的方法 ,比较伊贝沙坦 (Irb)与苯那普利 (Ben)治疗原发性高血压的疗效。方法 :70例 2 4h平均舒张压 (DBP)≥ 85 m m Hg的原发性高血压患者。经 1wk药物洗脱期、2 wk安慰剂期后 ,随机服用 Irb15 0 mg/d,qd或 Ben10 m g/ d,qd。 4wk末坐位 DBP≥ 90 m m Hg者剂量分别加量至 Irb30 0 mg/ d,qd或 Ben2 0 mg/ d,qd,继续服用4wk。分别观察安慰剂期末和 8wk末的 2 4h ABPM值和实验室检查值的变化。结果 :8wk末 Irb组 2 3例中需服 30 0 mg者占 75 % ,Ben组 2 5例中需服 2 0 mg占 85 %。 2组用药后各时点血压均较治疗前降低 ,且可保持血压的昼夜节律。 SBP/ DBP下降值在 2 4h、日间 (6 :0 0~ 2 2 :0 0 )、夜间 (2 2 :0 0~ 6 :0 0 ) Irb组分别为 (16 .2± 11.8) / (10 .0± 7.9)、(18.2± 6 .2 ) / (11.6± 4.5 )、(11.8± 4.0 ) / (7.0± 2 .7) mm Hg;Ben组分别为 (9.9± 10 .4) / (5 .1± 5 .7)、(11.1± 3.4) / (6 .3± 2 .9)、(4 .6± 4.9) / (2 .8±4.1) mm Hg。DBP下降值组间比较 P<0 .0 5 ;SBP下降值组间比较 P>0 .0 5。 2组降压 T/ P均大于 5 0 %。Ben组咳嗽发生率9% ,而 Irb组无。结论 :Irb降压幅度好于 Ben。两药降压的同时均不影响血压昼夜节律 ,降压 T/ AIM: To compare the antihypertensive effects between irbesartan and benazepril by 24 h ambulatory blood pressure monitoring (ABPM). METHODS: Seventy patients with 24 h mean diastolic blood pressure (DBP) ≥85 mmHg (1 mmHg=0 133 kPa) were randomly received either 150 mg irbesartan or benazepril 10 mg once a day for 4 wk, followed by doses doubled for another 4 wk in those patients with Se DBP≥90 mmHg. RESULTS: Blood pressure and heart rate were registered automatically at 20 min interval during day time (from 06:00 to 22:00) and 30 min interval during night time (from 22:00 to 06:00) using Space lab 90217 at baseline and at wk 8. Clinical safety , specific symptoms were examined also at baseline and at wk 2, 4, 6 and 8. 24 h mean SBP/DBP reductions from baseline in 24 h, day time, night time were (16 2±11 8)/(10 0±7 9), (18 2±6 2)/(11 6±4 5), and (11 8±4 0)/(7 0±2 7) mmHg respectively in irbesartan group ( n=23 ) and (9 9±10 4)/(5 1±5 7), (11 1±3 4)/(6 3±2 9), and (4 6±4 9)/(2 8±4 1) mmHg respectively in benazepril group ( n=20 ). There was significant difference in DBP decrease ( P <0 05) between irbesartan group and benazepril group. CONCLUSION: Irbesartan 150 300 mg once daily is more effective than benazepril 10 20 mg once daily in Chinese patients with essential hypertension.
出处 《中国临床药学杂志》 CAS 2001年第4期205-207,共3页 Chinese Journal of Clinical Pharmacy
关键词 动态血压 监测 伊贝沙坦 苯那普利 原发性高血压 药物治疗 ambulatory blood pressure monitoring irbesartan benazepril essential hypertension
  • 相关文献

参考文献8

  • 1[1]Eberhardt RT, Kevak RM, Kang PM, et al. Angiotensin Ⅱ receptor blockade: an innovative approach to cardiovascular pharmacology. J Clin Pharmacol, 1993, 33:1023
  • 2[2]Timmermans PB, Wong PC, Chiu AT, et al. Angiotensin Ⅱ receptors and angiotensin Ⅱ receptor antagonists. Pharmacol Rev, 1993, 45(Jun):205
  • 3[3]Cavras I. Bradykinin-mediated effects of ACE inhibition. Drug,1992, 42:1020
  • 4[4]Husain A. The chymase-angiotensin system in human. J Hypertens, 1993, 11:1155
  • 5[5]Lacourciere Y, Lefebvre J. Modulation of the reninangiotensin-aldosterone system and cough. Can J Cardiol,1995, 11(Suppl F): 33F
  • 6[6]Roberto F, Sergio A, Luca S, et al. 24 h blood pressure control by once-daily administration of irbesartan assessed by ambulatory blood pressure monitoring. J Hypertens, 1997, 15:1511
  • 7[7]Richard A, Richard AR, Lin CS, et al. Dose-related efficacy of irbesartan for hypertension. Hypertension, 1998, 31:1311
  • 8[8]Fletcher AE, Palmer AJ, Bulpitt CJ. Cough with angiotensin converting enzyme inhibitors: how much of a problem? J Hypertens, 1994, 12(Suppl 2):S43

同被引文献31

  • 1[3]Pouleur HG.Clinical overview of irbesartan:a new angiotensin Ⅱ receptor antagonist. Am J Hypertens, 1997, 10(12 pt 2): 318~324.
  • 2[4]Kahan T. The importance of left ventricular hypertrophy in human hypertension. J Hypertens, 1998,16(7): 23~29.
  • 3[5]Malmqvist K, kahan T, Edner M,et al.Regression of left ventricular hypertrophy in human hypertension with irbesartan. J Hypertens, 2001,19(6):1167~1176.
  • 4[6]Tonkon M,Awan N,Niazi I,et al.A study of the efficacy and safety of irbesartan in combination with conventional therapy, including ACE inhibitors, in heart failure. Irbesartan Heart Failure Group.Int J Clin Pract, 2000,54(1):11~14,16~18.
  • 5Wolng A,Clozel JP,Rein J,et al.Functional and biochemical analysis of angiotensin II-forming pathways in the human heart[J].Circ Res,1997;80:219-227
  • 6Schmitz D,Berk BC.Angiotensin II signal transduction stimulation of mutiple mitogen activated protein kinase pathways[J].Trends Endocrinol Metab,1997;8:261-6
  • 7Harris RC,Becker BN,Cheng HF.Acute and chronic mechanisms for regulating proximal tubule angiotensin II receptor expression[J].J Am Soc Nephrol,1997;8:306-13
  • 8Klahr S,Morrissey JJ.Comprative study of ACE inhibitors and angiotensin II receptor antagonist in interstitial scarring[J].Kidney Int,1997;52 (suppl 63):111-4
  • 9Gomez-Garre D,Largo R,Tejera N,et al.Activation of NF-κB in tubular epithelial cells of rats with intense proteinuria: Role of Angiotensin II and Endothelin-1[J].Hypertension,2001;37:1171-8
  • 10Ruiz-Ortega M,Lorenzo O,Ruperez M,et al.AngiotensinII activates nuclear transcription factor κB through AT1 and AT2 in vascular smooth muscle cells: molecular mechanisms[J].Circ Res,2000;86:1266-72

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部